par Blanc, Jeremy
;Carnot, Aurélien;Barthélémy, Philippe;Casert, Vinciane;Sautois, Brieuc;Van den Brande, Jan;Vanhaudenarde, Vincent;Staudacher, Lionel;Seront, Emmanuel;Debien, Veronique;Ameye, Lieveke;Kotecki, Nuria;Rothé, Françoise
;Rorive, Sandrine
;Fantoni, Jean Christophe;Tricard, Thibault;Roumeguère, Thierry;Awada, Ahmad;Martinez Chanza, Nieves
Référence Journal for ImmunoTherapy of Cancer, 13, 5
Publication Publié, 2025-05-01



Référence Journal for ImmunoTherapy of Cancer, 13, 5
Publication Publié, 2025-05-01
Article révisé par les pairs
Titre: |
|
Auteur: | Blanc, Jeremy; Carnot, Aurélien; Barthélémy, Philippe; Casert, Vinciane; Sautois, Brieuc; Van den Brande, Jan; Vanhaudenarde, Vincent; Staudacher, Lionel; Seront, Emmanuel; Debien, Veronique; Ameye, Lieveke; Kotecki, Nuria; Rothé, Françoise; Rorive, Sandrine; Fantoni, Jean Christophe; Tricard, Thibault; Roumeguère, Thierry; Awada, Ahmad; Martinez Chanza, Nieves |
Informations sur la publication: | Journal for ImmunoTherapy of Cancer, 13, 5 |
Statut de publication: | Publié, 2025-05-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Bladder Cancer |
Genitourinary Cancer | |
Immune Checkpoint Inhibitor | |
Neoadjuvant | |
MeSH keywords: | Humans |
Urinary Bladder Neoplasms -- drug therapy -- pathology -- mortality | |
Male | |
Female | |
Aged | |
Neoadjuvant Therapy -- methods | |
Antibodies, Monoclonal, Humanized -- therapeutic use -- pharmacology -- administration & dosage | |
Middle Aged | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use -- adverse effects | |
Cisplatin -- administration & dosage | |
Gemcitabine | |
Aged, 80 and over | |
Neoplasm Invasiveness | |
Deoxycytidine -- analogs & derivatives -- administration & dosage | |
Langue: | Anglais |
Identificateurs: | urn:issn:2051-1426 |
info:doi/10.1136/jitc-2025-012045 | |
info:pii/jitc-2025-012045 | |
info:pmid/40413024 | |
PMC12104948 |